• Epidemiology
• 37 min
  1. Assessment of obesity and classification of patients: historical perspectives and current practice

  • Prof. George Bray
• 40 min
  2. Epidemiology of obesity

  • Prof. Jacob Seidell
• Etiology and Causes
• 59 min
  3. Metabolic, adipose tissue and muscle predictors of obesity

  • Prof. Ian Macdonald
• 41 min
  4. Neural control of food intake and energy balance

  • Prof. Hans-Rudolf Berthoud
• 64 min
  5. Understanding obesity: genes and environment in the determination of body weight

  • Prof. Rudy Leibel
• 47 min
  6. Dietary determinants of obesity

  • Prof. Arne Astrup
• 42 min
  7. Physical inactivity as a determinant of obesity

  • Prof. Wim Saris
• 42 min
  8. Environmental causes of obesity: sociocultural, built environment and economic factors

  • Prof. Shiriki Kumanyika
• 29 min
  9. The developmental origins of obesity

  • Prof. David Barker
• Consequences of Obesity
• 46 min
  10. Obesity, dyslipoproteinemia and inflammation

  • Prof. Robert Eckel
• 23 min
  11. Pathophysiology and management of obesity related hypertension

  • Prof. Arya Sharma
• 22 min
  12. Disorders of overeating

  • Prof. Albert Stunkard
• 20 min
  13. Obesity, weight loss and health-related quality of life

  • Prof. Aila Rissanen
  • Dr. Jarmo Kaukua
• Treatment Options
• 44 min
  14. Lifestyle modification for weight control

  • Prof. Thomas Wadden
• 34 min
  15. Bariatric / obesity surgery

  • Prof. Henry Buchwald
• 48 min
  16. Can obesity be prevented in the current obesogenic environment?

  • Prof. Boyd Swinburn
• 28 min
  17. Pharmacotherapy for obesity: why it is needed

  • Prof. Joe Proietto
• 35 min
  18. Pharmacotherapy for obesity: hunger suppressors

  • Prof. Joe Proietto
• Latest Developments in the Field
• 60 min
  19. Body composition

  • Dr. Steven Heymsfield
• 56 min
  20. Adipose tissue metabolism and obesity

  • Dr. Max Lafontan
• 25 min
  21. Obesity, present and future therapies

  • Prof. Sir Stephen Bloom
• 42 min
  22. Energy expenditure in the lean and obese

  • Prof. Dale Schoeller
• 33 min
  23. Obesity and adiponectin

  • Prof. Philipp Scherer
• 44 min
  24. Ectopic fat: causes, consequences and treatment

  • Prof. Steven Smith
• 47 min
  25. Adipose-immune interactions in obesity

  • Dr. Vishwa Dixit
• 39 min
  26. Health benefits of intentional weight loss

  • Prof. Xavier Pi-Sunyer
• 39 min
  27. Childhood obesity: implications for current and future health

  • Prof. Peter T. Katzmarzyk
• 46 min
  28. The clinical assessment and management of child and adolescent obesity

  • Prof. Louise Baur
• Archived Lectures - These lectures may not cover the latest advances in the field
• 41 min
  29. Gastrointestinal peptides and food intake regulation

  • Prof. Sir Stephen Bloom
• 48 min
  30. Obesity and mortality: questions and controversy

  • Prof. David Allison
• 37 min
  31. Obesity, diabetes and the cluster of the metabolic syndrome

  • Prof. Peter Wilson
• 44 min
  32. New standards in weight management: recent and future drugs for the treatment of obesity

  • Prof. Luc Van Gaal
• 46 min
  33. Health economics of obesity: new insights

  • Dr. Anne Wolf
• 34 min
  34. Bariatric surgery: techniques and mechanisms of action

  • Prof. Walter Pories
• 39 min
  35. Childhood obesity: implications for future health

  • Prof. Peter T. Katzmarzyk
• 14 min
  36. Pharmacotherapy for obesity 1 - the need for pharmacotherapy in weight management

  • Prof. Joe Proietto
• 46 min
  37. Pharmacotherapy for obesity 2 - pharmacological agents in current use & under development

  • Prof. Joe Proietto

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Medical complications of obesity
3. Obesity is the primary risk factor for diabetes
4. Age-adjusted prevalence of hypertension vs. BMI
5. Metabolic syndrome: clinical identification
6. Twin epidemics: parallels in prevalence
7. Obesity and coronary heart disease mortality
8. Intentional weight loss and its health benefits
9. Data supporting life-style intervention
10. Weight loss and cardiovascular risk
11. US diabetes prevention program
12. Study interventions
13. Characteristics by treatment group assignment
14. DPP: lifestyle intervention
15. Dietary factors that affect energy intake
16. Weight-Reducing diet - recommended nutrients
17. DPP: effect of interventions on weight
18. DPP: mean change in leisure physical activity
19. DPP: cumulative incidence of diabetes
20. Mean change in blood pressure
21. Mean change in lipids (1)
22. Mean change in lipids (2)
23. Thrombogenic and inflammatory risk
24. Mean change in TPA
25. Mean change in fibrinogen
26. Mean change in CRP
27. CRP levels in obese postmenopausal women
28. Finnish diabetes prevention study
29. FDPS: goals of intervention
30. FDPS: effect of interventions on weight
31. FDPS: prevention of diabetes
32. FDPS: changes in clinical and metabolic variables
33. Hazard rate for diabetes and the change in weight
34. DPP and FDPS conclusions
35. LookAHEAD trial (1)
36. Look AHEAD trial (2)
37. Baseline characteristics of participants
38. LookAHEAD interventions
39. LookAHEAD: weight loss at 1-year
40. LookAHEAD: fitness change at 1-year
41. LookAHEAD: glycemia outcomes
42. LookAHEAD: blood pressure outcomes
43. LookAHEAD: lipid outcomes
44. LookAHEAD: other outcomes
45. LookAHEAD: conclusions
46. Trials of hypertension prevention, phase II
47. TOHP II: effect of intervention on weight
48. TOHP II: mean change in blood pressure
49. Effects of population-based BP reduction
50. Effect of modest weight loss on cholesterol
51. Effect of weight loss on HDL-C in type 2 diabetes
52. Weight loss: mechanisms for improvement in risks
53. Adipose tissue as endocrine cells
54. Obesity as a therapeutic target for prevention
55. Cancer incidence attributable to obesity
56. All cause mortality
57. Thank you

Topics Covered

• Medical complications of obesity
• Obesity is the primary risk factor for diabetes
• Age-adjusted prevalence of hypertension vs. BMI
• Metabolic syndrome: clinical identification
• Obesity and coronary heart disease mortality
• Data supporting life-style intervention
• Weight loss and cardiovascular risk
• US diabetes prevention program
• Study interventions
• DPP: lifestyle intervention
• Dietary factors that affect energy intake
• Weight-Reducing diet
• recommended nutrients
• Mean change in blood pressure
• Mean change in lipids
• Thrombogenic and inflammatory risk
• Mean change in TPA
• Mean change in fibrinogen
• Mean change in CRP
• Finnish diabetes prevention study
• Hazard rate for diabetes and the change in weight
• LookAHEAD trial
• Trials of hypertension prevention, phase II
• Effects of population-based BP reduction
• Effect of modest weight loss on cholesterol
• Adipose tissue as endocrine cells
• Obesity as a therapeutic target for prevention
• Cancer incidence attributable to obesity

Links

Series:

• Obesity

Categories:

• Clinical Practice
• Metabolism & Nutrition

Therapeutic Areas:

• Cardiovascular & Metabolic

Talk Citation

Publication History

• Published on May 31, 2009

Financial Disclosures

• Prof. Xavier Pi-Sunyer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.